Posted in | News | Imaging

Malvern’s Application Note Suggests NIR-CI for Tablet Deconstruction

Chemical imaging specialists at Malvern Instruments have recently published an application note demonstrating that by reverse engineering pharmaceutical tablets using data from the SyNIRgi near infrared chemical imaging (NIR-CI) system they could determine extensive and detailed information about the formulations and processing techniques used to create each dosage. This has valuable applications in troubleshooting product failures.

The application note, entitled ‘NIR chemical imaging for tablet deconstruction: A case study for solid dosage forms’ can be downloaded from Malvern’s extensive knowledge database at: www.malvern.com/nircitablets

While high performance liquid chromatography (HPLC) can provide basic information about a product’s makeup, the application of NIR-CI adds novel information relating to its manufacture. Using Malvern’s ISys chemical imaging analysis software to evaluate the size, shape and proximity of chemical components, SyNIRgi’s global imaging approach provides a visual representation of a product’s composition and engineered structure.

SyNIRgi delivers robust automated sampling capabilities that deliver rapid data acquisition as well as advanced data analysis via an easy-to-use interface.

The NIR-CI technique demonstrated in Malvern’s new application note takes advantage of both SyNIRgi hardware and ISys software’s advanced features. This type of reverse engineering has demonstrated unparalleled ability to help understand product failures and can primarily be used for trouble-shooting. The wealth of chemical and physical information in a chemical image provides a fingerprint of the tablet’s production properties and ultimately, its performance.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.